David J. Woodhouse

Companies

• Surrozen, Inc./DEBoard member Aug 16, 2021 to now¹
• NGM Biopharmaceuticals (United States)Board member Apr 3, 2019 to Apr 8, 2024²
• NGM Biopharmaceuticals (United States)Chief executive officer Apr 3, 2019 to Apr 8, 2024²
• NGM Biopharmaceuticals (United States)Chief financial officer Apr 3, 2019 to Feb 6, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NGM Biopharmaceuticals (United States)0 shares³Apr 5, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 5, 2024U 97,654 shares of NGM Biopharmaceuticals (United States)³
• Apr 5, 2024U 23,993 shares of NGM Biopharmaceuticals (United States)³
• Jan 16, 2024Shares withheld for tax 13,032 shares at $1.34 of NGM Biopharmaceuticals (United States)⁴
• Mar 2, 2023Granted 127,200 shares of NGM Biopharmaceuticals (United States)⁵
• Dec 29, 2021Exercised options 4,667 shares at $8.14 of NGM Biopharmaceuticals (United States)⁶
• Dec 29, 2021Exercised options 12,987 shares at $7.70 of NGM Biopharmaceuticals (United States)⁶
• Nov 18, 2021Sold 15,000 shares at $20.02 of NGM Biopharmaceuticals (United States)⁷
• Nov 18, 2021Exercised options 15,000 shares at $7.54 of NGM Biopharmaceuticals (United States)⁷